http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011319785-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a01154a8cb6a02e643fb0679802ee245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f1b204ccd4c80cc32b0b8b61741a93e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6127b45670721d8abd926e09de1f9d1f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2560-0219
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-349
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-374
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4094
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-374
filingDate 2011-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f04ce68d9c277dab60d75b21d39c9a3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3361f2be92318f8b1c3ac72024c38590
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e34c6576deed80929af2f708fbc55a9
publicationDate 2011-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2011319785-A1
titleOfInvention Implantable Systems and Methods for Identifying a Contra-ictal Condition in a Subject
abstract Systems and methods of monitoring a subject's neurological condition are provided. In some embodiments, the method includes the steps of analyzing a physiological signal (such as an EEG) from a subject to determine if the subject is in a contra-ictal condition; and if the subject is in a contra-ictal condition, providing an indication (e.g., to the subject and/or to a caregiver) that the subject is in the contra-ictal condition. The systems and methods may utilize a minimally invasive, leadless device to monitor the subject's condition. In some embodiments, if the subject is in a pro-ictal condition, the method includes the step of providing an indication (such as a red light) that the subject is in the pro-ictal condition.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9320900-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9375573-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102387573-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011201944-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9480845-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8849390-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9259591-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9289595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109908473-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8588933-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9326720-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009062682-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9643019-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8781597-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8786624-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786694-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9113801-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3498334-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9622675-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8855775-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015164431-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9014810-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10610163-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8868172-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11738191-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9898656-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010168604-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9421373-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010145176-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9343923-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9935498-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8295934-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406317-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8594806-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010302270-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9445730-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9788744-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190078678-A
priorityDate 2007-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6549804-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008091090-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006167371-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300

Total number of triples: 72.